Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.

ClinicalTrials.gov ID: NCT00790192

Public ClinicalTrials.gov record NCT00790192. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 4:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Clinical Trial to Study the Efficacy and Safety of Two Doses of Lurasidone in Acutely Psychotic Subjects With Schizophrenia (PEARL 3)

Study identification

NCT ID
NCT00790192
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
488 participants

Conditions and interventions

Conditions

Interventions

  • Lurasidone Drug
  • Quetiapine XR Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2008
Primary completion
Jun 30, 2010
Completion
Jun 30, 2010
Last update posted
Mar 16, 2016

2008 – 2010

United States locations

U.S. sites
29
U.S. states
12
U.S. cities
26
Facility City State ZIP Site status
K&S Professional Research Services, LLC Little Rock Arkansas 72201
Woodland International Research Group Little Rock Arkansas 72211
Clinical Pharmacological Studies, Inc. Cerritos California 90703
Comprehensive Neuroscience, Inc Cerritos California 90703
Clinical Innovations, Inc. Costa Mesa California 92647
Synergy Escondido Escondido California 92025
Collaborative Neuroscience Network Garden Grove California 92645
Apostle Clinical Trials, Inc. Long Beach California 90813
California Clinical Trials Paramount California 90723
Pasadena Research Institute Pasadena California 91107
CNRI-Los Angeles. LLC Pico Rivera California 90660
Clinical Innovations, Inc. Riverside California 92647
CNRI-San Diego San Diego California 92126
UCSD Medical Center Sandeigo California 92103
Segal Institute for Clinical Research Highlands Ranch Colorado 80103
Comprehensive Neuroscience, Inc. Washington D.C. District of Columbia 20016
Florida Clinical Research Center Bradenton Florida 34208
Florida Clinical Research Center, LLC Fruitland Park Florida 34731
Lake Charles Clinical Trials Lake Charles Louisiana 70601
Booker, J. Gary, MD. APMC Shreveport Louisiana 71104
Precise Clinical Research Flowood Mississippi 39232
St. Charles Psychiatric Associates Saint Charles Missouri 63301
St. Louis Research, Inc. St Louis Missouri 63118
CRI Worldwide Willingboro New Jersey 08046
Comprehensive Neuroscience, Inc Holliswood New York 11423
Segal Institute for Clinical Research Winston-Salem North Carolina 27104
Community Clinical Research Austin Texas 78729
Future Search Trials of Neurology Austin Texas 78756
Pillar Clinical Research Dallas Texas 75243

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00790192, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 16, 2016 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00790192 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →